April 23, 2015
Astellas Nominates Director and Audit & Supervisory Board MemberTokyo, Japan, April 23, 2015 - Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Yoshihiko Hatanaka) announced that, at a meeting of its Board of Directors held today, it decided on the following candidates for Director and Audit & Supervisory Board Member to be newly elected at the Ordinary General Meeting of Shareholders scheduled for June 17, 2015.
[Candidate of Director]Outside Director Yoshiharu Aizawa
[Director to be retired]Outside Director Naoki Aikawa
[Candidate of Audit & Supervisory Board Member]
Outside Audit & Supervisory Board Member Hitoshi Kanamori
Board of Directors
Masafumi Nogimori (Representative Director and Chairman)
Yoshihiko Hatanaka (Representative Director, President and Chief Executive Officer) Yoshirou Miyokawa (Representative Director, Executive Vice President and Chief
Administrative Officer & Chief Compliance Officer) Yutaka Kase (Outside Director)
Hironobu Yasuda (Outside Director) Etsuko Okajima (Outside Director) Yoshiharu Aizawa (Outside Director)
Audit & Supervisory Board
Go Otani (Audit & Supervisory Board Member)
Tomokazu Fujisawa (Audit & Supervisory Board Member)
Shigeru Nishiyama (Outside Audit & Supervisory Board Member) Toshiko Oka (Outside Audit & Supervisory Board Member) Hitoshi Kanamori (Outside Audit & Supervisory Board Member)
#######
Contacts for inquiries or additional information
Astellas Pharma Inc. Corporate Communications
Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en/
distributed by |